113 related articles for article (PubMed ID: 2869458)
1. Different effects of dynorphin A on in vitro guinea pig hippocampal CA3 pyramidal cells with various degrees of paired-pulse facilitation.
Iwama T; Ishihara K; Satoh M; Takagi H
Neurosci Lett; 1986 Jan; 63(2):190-4. PubMed ID: 2869458
[TBL] [Abstract][Full Text] [Related]
2. Characterization of opioid receptors modulating the function of capsaicin-sensitive neurons in guinea-pig atria.
Mantelli L; Amerini S; Rubino A; Ledda F
Eur J Pharmacol; 1990 May; 180(2-3):325-30. PubMed ID: 1973118
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of stimulation strength in mouse vas deferens on inhibition of neuroeffector transmission by receptor type selective opioids.
Ramme D; Illes P
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):57-61. PubMed ID: 2869418
[TBL] [Abstract][Full Text] [Related]
4. Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro.
Moore SD; Madamba SG; Schweitzer P; Siggins GR
J Neurosci; 1994 Feb; 14(2):809-20. PubMed ID: 7905518
[TBL] [Abstract][Full Text] [Related]
5. Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism.
Madamba SG; Schweitzer P; Siggins GR
J Neurophysiol; 1999 Oct; 82(4):1768-75. PubMed ID: 10515966
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of mu, delta, and kappa opioid agonists on adenylate cyclase activity.
De Montis GM; Devoto P; Preti A; Tagliamonte A
J Neurosci Res; 1987; 17(4):435-9. PubMed ID: 2887665
[TBL] [Abstract][Full Text] [Related]
7. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
Iyengar S; Kim HS; Wood PL
Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
[TBL] [Abstract][Full Text] [Related]
8. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
Grider JR; Makhlouf GM
Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
[TBL] [Abstract][Full Text] [Related]
9. Lack of evidence of kappa2-selective activation of G-proteins: kappa opioid receptor stimulation of [35S] GTPgammaS binding in guinea pig brain.
Childers SR; Xiao R; Vogt L; Sim LJ
Biochem Pharmacol; 1998 Jul; 56(1):113-20. PubMed ID: 9698095
[TBL] [Abstract][Full Text] [Related]
10. Mu opioid receptor activation reduces inhibitory postsynaptic potentials in hippocampal CA3 pyramidal cells of rat and guinea pig.
Caudle RM; Chavkin C
J Pharmacol Exp Ther; 1990 Mar; 252(3):1361-9. PubMed ID: 1969476
[TBL] [Abstract][Full Text] [Related]
11. Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus.
Dunwiddie TV; Johnson KJ; Proctor WR
Br J Pharmacol; 1987 Jul; 91(3):523-30. PubMed ID: 3038241
[TBL] [Abstract][Full Text] [Related]
12. Magnetic fields differentially inhibit mu, delta, kappa and sigma opiate-induced analgesia in mice.
Kavaliers M; Ossenkopp KP
Peptides; 1986; 7(3):449-53. PubMed ID: 3022253
[TBL] [Abstract][Full Text] [Related]
13. Effects of dynorphin A (1-17), dynorphin A (1-13) and D-ala2-D-leu5-enkephalin on the excitability of pyramidal cells in CA1 and CA2 of the rat hippocampus in vitro.
Vidal C; Maier R; Zieglgänsberger W
Neuropeptides; 1984 Dec; 5(1-3):237-40. PubMed ID: 6152322
[TBL] [Abstract][Full Text] [Related]
14. U-50,488H inhibits dynorphin and glutamate release from guinea pig hippocampal mossy fiber terminals.
Gannon RL; Terrian DM
Brain Res; 1991 May; 548(1-2):242-7. PubMed ID: 1678297
[TBL] [Abstract][Full Text] [Related]
15. Possible mechanism involved in the inhibitory action of U-50, 488H, an opioid kappa agonist, on guinea pig hippocampal CA3 pyramidal neurons in vitro.
Iwama T; Ishihara K; Takagi H; Satoh M
J Pharmacobiodyn; 1987 Oct; 10(10):564-70. PubMed ID: 3326929
[TBL] [Abstract][Full Text] [Related]
16. Dynorphin prolongs the action potential duration of mouse sensory ganglion neurons by decreasing a K+ conductance whereas the specific kappa opioid, U-50,488H does so by increasing a Ca2+ conductance.
Shen KF; Crain SM
Prog Clin Biol Res; 1990; 328():343-6. PubMed ID: 1968268
[No Abstract] [Full Text] [Related]
17. TENA, a selective kappa opioid receptor antagonist.
Portoghese PS; Takemori AE
Life Sci; 1985 Feb; 36(8):801-5. PubMed ID: 2983171
[TBL] [Abstract][Full Text] [Related]
18. Effect of opioid peptides on circular muscle of canine duodenum.
Bauer AJ; Szurszewski JH
J Physiol; 1991 Mar; 434():409-22. PubMed ID: 1673718
[TBL] [Abstract][Full Text] [Related]
19. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
Scheurer U; Wenger F; Caliezi A; Drack E; Varga L; Halter F
J Pharmacol Exp Ther; 1990 Mar; 252(3):1324-30. PubMed ID: 1969475
[TBL] [Abstract][Full Text] [Related]
20. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
